Sbc Medical Group Holdings INC (SBCWW) — SEC Filings

Q: What are the key financial highlights for Sbc Medical Group Holdings INC?

Key financial highlights for Sbc Medical Group Holdings INC are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Sbc Medical Group Holdings INC?

Key executives at Sbc Medical Group Holdings INC are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Sbc Medical Group Holdings INC stock?

Risk factors for Sbc Medical Group Holdings INC (SBCWW) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Sbc Medical Group Holdings INC?

Forward-looking statements and predictions from Sbc Medical Group Holdings INC are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Sbc Medical Group Holdings INC. Recent 8-K filing on Dec 31, 2025. AI-decoded analysis of earnings, risk factors, and insider trades

View Sbc Medical Group Holdings INC on SEC EDGAR

Overview

Sbc Medical Group Holdings INC (SBCWW) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 31, 2025: SBC Medical Group Holdings Inc. filed an 8-K on December 31, 2025, reporting on events including Regulation FD disclosures, other events, and financial statements. The company, formerly known as Pono Capital Two, Inc., is incorporated in Delaware and headquartered in Irvine, California.

Sentiment Summary

Across 47 filings, the sentiment breakdown is: 2 bullish, 3 bearish, 41 neutral, 1 mixed. The dominant filing sentiment for Sbc Medical Group Holdings INC is neutral.

Filing Type Overview

Sbc Medical Group Holdings INC (SBCWW) has filed 19 8-K, 6 10-Q, 2 DEF 14A, 2 10-K/A, 2 10-K, 1 S-1, 8 SC 13D/A, 4 SC 13G/A, 2 SC 13G, 1 SC 13D with the SEC between Jan 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (47)

SBC Medical Group Holdings Inc. Files 8-K — 8-K · Dec 31, 2025 Risk: low
SBC Medical Group Holdings Inc. filed an 8-K on December 31, 2025, reporting on events including Regulation FD disclosures, other events, and financial statemen
SBC Medical Group Holdings Inc. Files 8-K — 8-K · Dec 15, 2025 Risk: low
SBC Medical Group Holdings Inc. filed an 8-K on December 15, 2025, reporting events as of December 13, 2025. The filing indicates the company's former name was
SBC Medical Group's Q3 Net Income Soars 352% Amidst Revenue Dip — 10-Q · Nov 14, 2025 Risk: medium
SBC Medical Group Holdings Inc. reported a significant increase in net income for the three months ended September 30, 2025, reaching $12,833,326, up from $2,83
SBC Medical Group Holdings Files 8-K — 8-K · Nov 13, 2025 Risk: low
SBC Medical Group Holdings Inc. filed an 8-K on November 13, 2025, reporting on other events and financial statements. The company, formerly known as Pono Capit
SBC Medical Group's Q2 Net Income Plummets 87% Amid Revenue Dip — 10-Q · Aug 13, 2025 Risk: high
SBC Medical Group Holdings Inc. reported a significant decline in net income for the three months ended June 30, 2025, falling to $2,439,852 from $18,557,325 in
SBC Medical Group Holdings Inc. Files 8-K — 8-K · Jul 17, 2025 Risk: low
On July 17, 2025, SBC Medical Group Holdings Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhib
SBC Medical Group Holdings Files 8-K — 8-K · Jun 30, 2025 Risk: low
SBC Medical Group Holdings Inc. (formerly Pono Capital Two, Inc.) filed an 8-K on June 30, 2025, reporting events as of June 27, 2025. The filing primarily conc
SBC Medical Group Holdings Files 8-K — 8-K · Jun 18, 2025 Risk: low
SBC Medical Group Holdings Inc. (formerly Pono Capital Two, Inc.) filed an 8-K on June 18, 2025, reporting events as of June 13, 2025. The filing indicates amen
SBC Medical Group to Declassify Board, Boost Governance — DEF 14A · May 28, 2025 Risk: low
SBC Medical Group Holdings Inc. (SBCWW) is holding its 2025 annual meeting virtually on June 13, 2025, at 10:00 a.m. Japan Standard Time. Key proposals include
SBC Medical Group Holdings Inc. Files Q1 2025 10-Q — 10-Q · May 15, 2025 Risk: low
SBC Medical Group Holdings Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, inc
SBC Medical Group Holdings Files 10-K Amendment — 10-K/A · May 9, 2025 Risk: low
SBC Medical Group Holdings Inc. filed an amendment (Amendment No. 2) to its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company,
SBC Medical Group Holdings Files 10-K/A Amendment — 10-K/A · Apr 30, 2025 Risk: medium
SBC Medical Group Holdings Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly known as Pon
SBC Medical Group Holdings Inc. Reports Director and Officer Changes — 8-K · Apr 2, 2025 Risk: medium
SBC Medical Group Holdings Inc. announced on March 27, 2025, changes related to its board of directors and officers, including the departure of certain individu
SBC Medical Group Holdings Inc. Files 2024 10-K — 10-K · Mar 28, 2025 Risk: medium
SBC Medical Group Holdings Inc. filed its 2024 10-K on March 28, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly Pono Capital
SBC Medical Group Holdings Files 8-K — 8-K · Feb 18, 2025 Risk: low
SBC Medical Group Holdings Inc. (formerly Pono Capital Two, Inc.) filed an 8-K on February 18, 2025, reporting an event on February 12, 2025. The filing indicat
SBC Medical Group Holdings Files 8-K — 8-K · Dec 20, 2024 Risk: medium
SBC Medical Group Holdings Inc. (formerly Pono Capital Two, Inc.) filed an 8-K on December 20, 2024, reporting a change in its corporate structure and potential
SBC Medical Group Holdings Inc. Files 10-Q — 10-Q · Nov 13, 2024 Risk: low
SBC Medical Group Holdings Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly Pono Capital Two, Inc., is incorporated in Delawa
SBC Medical Group Holdings Files for IPO — S-1 · Oct 8, 2024 Risk: medium
SBC Medical Group Holdings Inc. filed an S-1 registration statement on October 8, 2024, for its initial public offering. The company, formerly known as Pono Cap
ZUU Co. Ltd. Amends SBC Medical Stake Filing — SC 13D/A · Oct 1, 2024 Risk: medium
ZUU Co. Ltd. and its affiliated entities, including Kazumasa Tomita, have filed an amendment (Amendment No. 7) to their Schedule 13D concerning SBC Medical Grou
ZUU Co. Ltd. Amends SBC Medical Stake — SC 13D/A · Sep 24, 2024 Risk: medium
On September 24, 2024, ZUU Co. Ltd. and its group members, Kazumasa Tomita and ZUU FUNDERS CO. LTD, filed an amendment (Amendment No. 6) to their Schedule 13D r
Aikawa Amends SBC Medical Group Holdings Stake — SC 13D/A · Sep 23, 2024 Risk: medium
Yoshiyuki Aikawa has amended their Schedule 13D filing for SBC Medical Group Holdings Inc. The amendment, filed on September 23, 2024, relates to the acquisitio
SBC Medical Acquires Pono Capital Two — 8-K · Sep 20, 2024 Risk: medium
SBC Medical Group Holdings Inc. announced on September 17, 2024, that it has entered into a definitive agreement to acquire Pono Capital Two, Inc. The acquisiti
ZUU Co. Ltd. Group Amends SBC Medical 13D Filing — SC 13D/A · Sep 19, 2024 Risk: medium
On September 19, 2024, ZUU Co. Ltd. and its group members, Kazumasa Tomita and ZUU FUNDERS CO. LTD, filed an amendment to their Schedule 13D regarding SBC Medic
Pono Capital Two, Inc. Files 8-K on Security Holder Votes — 8-K · Aug 29, 2024 Risk: low
Pono Capital Two, Inc. filed an 8-K on August 29, 2024, reporting on matters submitted to a vote of security holders and a Regulation FD disclosure. The filing
Pono Capital Two Announces Business Combination Agreement — 8-K · Aug 23, 2024 Risk: medium
Pono Capital Two, Inc. announced on August 22, 2024, that it has entered into a definitive agreement for a business combination with a target company. The filin
Pono Capital Two (PONO) Ownership Filing Amendment — SC 13D/A · Aug 20, 2024 Risk: medium
On August 20, 2024, Kazumasa Tomita, ZUU Funders Co. Ltd, and ZUU Target Fund for SBC Medical Group HD Investment Partners filed an amendment (Amendment No. 4)
Pono Capital Two, Inc. Files Q2 2024 10-Q Report — 10-Q · Aug 16, 2024 Risk: low
Pono Capital Two, Inc. filed its quarterly report for the period ending June 30, 2024. The company, incorporated in Delaware, is based in Honolulu, Hawaii, and
Pono Capital Two Files 8-K on Definitive Agreement — 8-K · Aug 12, 2024 Risk: low
Pono Capital Two, Inc. filed an 8-K on August 8, 2024, reporting the entry into a material definitive agreement and the filing of financial statements and exhib
Pono Capital Two, Inc. Sees Ownership Update — SC 13D/A · Jul 26, 2024 Risk: medium
On July 26, 2024, Pono Capital Two, Inc. filed an amendment (Amendment No. 3) to its Schedule 13D. The filing indicates a change in beneficial ownership by ZUU
SC 13G/A Filing — SC 13G/A · Jun 28, 2024
Pono Capital Two, Inc. Files Q1 2024 10-Q — 10-Q · May 20, 2024 Risk: medium
Pono Capital Two, Inc. filed its Q1 2024 10-Q report on May 20, 2024, covering the period ending March 31, 2024. The company's primary business involves the for
Pono Capital Two Faces Delisting Notice — 8-K · May 8, 2024 Risk: high
Pono Capital Two, Inc. filed an 8-K on May 8, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, effective May 6,
Pono Capital Two, Inc. Files 8-K on Definitive Agreement — 8-K · Apr 23, 2024 Risk: medium
Pono Capital Two, Inc. filed an 8-K on April 23, 2024, reporting the entry into a material definitive agreement and filing financial statements and exhibits. Th
Pono Capital Two (PTWO) Faces Nasdaq Delisting — 8-K · Apr 4, 2024 Risk: high
Pono Capital Two, Inc. filed an 8-K on April 4, 2024, to report a notice of delisting or failure to satisfy continued listing rules. The company's common stock
Pono Capital Two, Inc. Sees Ownership Update — SC 13D/A · Mar 21, 2024 Risk: medium
On March 21, 2024, Pono Capital Two, Inc. filed an amendment (SC 13D/A) to its Schedule 13D. This filing indicates a change in beneficial ownership by ZUU Co. L
Pono Capital Two, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 19, 2024 Risk: low
Pono Capital Two, Inc. (SBCWW) filed a Annual Report (10-K) with the SEC on March 19, 2024. Pono Capital Two, Inc. filed its annual report for the fiscal year e
SC 13G/A Filing — SC 13G/A · Mar 1, 2024
Pono Capital Two Files 8-K on Definitive Agreement — 8-K · Mar 1, 2024 Risk: medium
Pono Capital Two, Inc. (PTWO) entered into a material definitive agreement on February 27, 2024, related to the creation of a direct financial obligation. The c
Pono Capital Two Sees Ownership Update — SC 13D/A · Feb 29, 2024 Risk: medium
On February 29, 2024, Pono Capital Two, Inc. filed an amendment to its Schedule 13D. The filing indicates a change in beneficial ownership by ZUU Co. Ltd., Kazu
SC 13G/A Filing — SC 13G/A · Feb 22, 2024
SC 13G Filing — SC 13G · Feb 14, 2024
Polar Asset Mgmt. Holds 2.0% Stake in Aerwins Technologies — SC 13G/A · Feb 12, 2024 Risk: low
Polar Asset Management Partners Inc. filed an amended SC 13G/A on February 12, 2024, disclosing their beneficial ownership in Aerwins Technologies Inc. (formerl
Wolverine Asset Management Takes 9.9% Stake in Pono Capital Two — SC 13G · Feb 8, 2024 Risk: low
Wolverine Asset Management, LLC, a Chicago-based investment firm, reported owning 1,000,000 shares of Pono Capital Two, Inc.'s Class A Common Stock as of Decemb
Pono Capital Two 8-K Signals Potential Charter Amendments or Shareholder Vote — 8-K · Feb 8, 2024 Risk: medium
Pono Capital Two, Inc. filed an 8-K on February 8, 2024, reporting an event that occurred on February 5, 2024. The filing indicates that the company, a Special
ZUU Co. Ltd. Group Takes 9.9% Stake in Pono Capital Two — SC 13D · Feb 6, 2024
ZUU Co. Ltd., a Japanese financial media company, along with ZUU Funders Co. Ltd. and ZUU Target Fund for SBC Medical Group HD Investment Partners, has acquired
Pono Capital Two, Inc. Announces Special Meeting of Stockholders on February 5, 2024 — DEF 14A · Jan 23, 2024 Risk: low
Pono Capital Two, Inc. (SBCWW) filed a Proxy Statement (DEF 14A) with the SEC on January 23, 2024. Special Meeting of Stockholders scheduled for February 5, 202
Pono Capital Two Files 8-K on Material Agreement, Soliciting Material — 8-K · Jan 18, 2024
Pono Capital Two, Inc. filed an 8-K on January 18, 2024, reporting an event on January 11, 2024, related to an 'Entry into a Material Definitive Agreement' and

Risk Profile

Risk Assessment: Of SBCWW's 41 recent filings, 3 were flagged as high-risk, 20 as medium-risk, and 18 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Sbc Medical Group Holdings INC's most recent 10-Q filing (Nov 14, 2025):

Revenue: $43,353,235
Net Income: $12,833,326
EPS: $0.12
Cash Position: $127,431,318

Key Executives

Kazumasa Tomita
Yoshiyuki Aikawa
Randal D. Murdock
Christopher L. Gust
Robert R. Bellick
808-892-6611

Industry Context

The healthcare services industry, particularly in areas like medical groups, is characterized by evolving reimbursement models, increasing regulatory scrutiny, and a growing demand for specialized services. Consolidation is also a trend, with larger entities acquiring smaller practices. Companies often rely on strong referral networks and efficient operational management to maintain profitability.

Top Tags

sec-filing (9) · ownership-change (9) · amendment (7) · corporate-action (6) · financials (6) · warrants (5) · spac (5) · 8-K (4) · disclosure (4) · schedule-13d (4)

Key Numbers

Exercise Price: 11.50 — Per share exercise price for redeemable warrants
Net Income (Q3 2025): $12.8M — Increased 352% from $2.8M in Q3 2024
Total Revenues (Q3 2025): $43.4M — Decreased 18.3% from $53.1M in Q3 2024
Total Revenues (9M 2025): $134.0M — Decreased 16.7% from $161.0M in 9M 2024
Related Party Accounts Receivable: $58.6M — Increased from $28.8M at Dec 31, 2024
Cash and Cash Equivalents: $127.4M — Increased from $125.0M at Dec 31, 2024
Gain on Redemption of Life Insurance Policies: $8.7M — Recognized in 9M 2025, not present in 9M 2024
Treasury Stock (at cost): $7.7M — Increased from $2.7M at Dec 31, 2024
Common Stock Outstanding: 102,576,943 — As of October 31, 2025
Basic and Diluted EPS (Q3 2025): $0.12 — Increased from $0.03 in Q3 2024
Basic and Diluted EPS (9M 2025): $0.36 — Decreased from $0.42 in 9M 2024
SEC File Number: 001-41462 — Identifies the company's filing with the SEC
IRS Employer Identification No.: 88-1192288 — Tax identification number for the company
Net Income (Q2 2025): $2.4M — Down 86.8% from $18.6M in Q2 2024
Total Revenues (Q2 2025): $43.4M — Down 18.3% from $53.1M in Q2 2024

Forward-Looking Statements

{"claim":"Polar Asset Management Partners Inc. will maintain its stake in Aerwins Technologies Inc. for the foreseeable future.","entity":"Polar Asset Management Partners Inc.","targetDate":"12/31/2024","confidence":"medium"}
{"claim":"Wolverine Asset Management will maintain or increase its stake in Pono Capital Two, Inc. in the near term.","entity":"Wolverine Asset Management, LLC","targetDate":"Q2 2024","confidence":"medium"}
{"claim":"Pono Capital Two, Inc. will announce a definitive business combination target.","entity":"Pono Capital Two, Inc.","targetDate":"Q3 2024","confidence":"medium"}
{"claim":"Pono Capital Two, Inc. will announce a shareholder meeting to vote on an extension to complete a business combination.","entity":"Pono Capital Two, Inc.","targetDate":"2024-03-31","confidence":"medium"}
{"claim":"The company will amend its charter to allow for a longer period to identify and complete a merger target.","entity":"Pono Capital Two, Inc.","targetDate":"2024-06-30","confidence":"medium"}

Related Companies

SBC · PTWO · PONO · PTWOU

Frequently Asked Questions

What are the latest SEC filings for Sbc Medical Group Holdings INC (SBCWW)?

Sbc Medical Group Holdings INC has 47 recent SEC filings from Jan 2024 to Dec 2025, including 19 8-K, 8 SC 13D/A, 6 10-Q. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of SBCWW filings?

Across 47 filings, the sentiment breakdown is: 2 bullish, 3 bearish, 41 neutral, 1 mixed. The dominant sentiment is neutral.

Where can I find Sbc Medical Group Holdings INC SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Sbc Medical Group Holdings INC (SBCWW) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Sbc Medical Group Holdings INC?

Key financial highlights from Sbc Medical Group Holdings INC's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for SBCWW?

The investment thesis for SBCWW includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Sbc Medical Group Holdings INC?

Key executives identified across Sbc Medical Group Holdings INC's filings include Kazumasa Tomita, Yoshiyuki Aikawa, Randal D. Murdock, Christopher L. Gust, Robert R. Bellick and 1 others.

What are the main risk factors for Sbc Medical Group Holdings INC stock?

Of SBCWW's 41 assessed filings, 3 were flagged high-risk, 20 medium-risk, and 18 low-risk.

What are recent predictions and forward guidance from Sbc Medical Group Holdings INC?

Recent forward-looking statements from Sbc Medical Group Holdings INC include guidance on {"claim":"Polar Asset Management Partners Inc. will maintain its stake in Aerwins Technologies Inc. for the foreseeable and 4 other predictions.